A Therapeutic Lead Compound for Diabetic Kidney Disease with a Unique Lipophagy Activation Mechanism: SA-OR29

Journal article

Peer reviewed

Rachel Njeim, Haley Gye, Colin Bradshaw Kelly, Cole M. Foster, Judith T. Molina David, Sandra M. Merscher, Marc Giulianotti, Alessia Fornoni and Hassan Ali

Journal of the American Society of Nephrology, Vol.35(10S)

2024-10

Metrics

8 Record Views

Title: A Therapeutic Lead Compound for Diabetic Kidney Disease with a Unique Lipophagy Activation Mechanism
Creators: Rachel Njeim - University of Miami
Haley Gye - University of Miami
Colin Bradshaw Kelly - University of Miami Miller School of Medicine, Miami, Florida, United States
Cole M. Foster - University of Miami Miller School of Medicine, Miami, Florida, United States
Judith T. Molina David - University of Miami Miller School of Medicine (United States, Miami)
Sandra M. Merscher - University of Miami
Marc Giulianotti - University of Minnesota System
Alessia Fornoni - University of Miami
Hassan Ali - University of Miami
Publication Details: Journal of the American Society of Nephrology, Vol.35(10S)
Academic Unit: Peggy and Harold Katz Family Drug Discovery Center; Miller School of Medicine; UMMG Dept of Medicine - Nephrology & Hypertension Div
Language: English
Resource Type: Journal article
Record Identifier: 991032453311002976